✕
Login
Register
Back to News
Barrington Research Maintains Outperform on Cimpress, Raises Price Target to $113
Benzinga Newsdesk
www.benzinga.com
Positive 83.2%
Neg 0%
Neu 0%
Pos 83.2%
Barrington Research analyst Kevin Steinke maintains Cimpress (NASDAQ:
CMPR
) with a Outperform and raises the price target from $95 to $113.
Comments
No comments yet. Be the first!
Join the discussion
Login to comment
Login to comment